Note and Warrant Subscription Agreement Sample Contracts
CALPIAN, INC. NOTE AND WARRANT SUBSCRIPTION AGREEMENTNote and Warrant Subscription Agreement • January 6th, 2011 • Calpian, Inc. • Dolls & stuffed toys • Texas
This NOTE AND WARRANT PURCHASE AGREEMENT (“Agreement”) made as of the 31st day of December, 2010 by and between the undersigned subscriber (the “Subscriber”) and CALPIAN, INC., a Texas corporation (the “Corporation”), having its principal office at 500 N. Akard Street, Suite 2850, Dallas, Texas 75201.
CALPIAN, INC. NOTE AND WARRANT SUBSCRIPTION AGREEMENTNote and Warrant Subscription Agreement • December 4th, 2015 • Calpian, Inc. • Services-business services, nec • Texas
This NOTE AND WARRANT PURCHASE AGREEMENT (“Agreement”) made as of the 30th day of November, 2015 by and between the undersigned subscriber (the “Subscriber”) and CALPIAN, INC., a Texas corporation (the “Corporation”), having its principal office at 500 N. Akard Street, Suite 2850, Dallas, Texas 75201.
EXHIBIT 10.1 NOTE AND WARRANT SUBSCRIPTION AGREEMENT INTERLEUKIN GENETICS, INC. This Note and Warrant Subscription Agreement (this "Agreement") is made between Interleukin Genetics, Inc., a Delaware corporation (the "Company"), and the undersigned...Note and Warrant Subscription Agreement • November 7th, 2002 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
NOTE AND WARRANT SUBSCRIPTION AGREEMENTNote and Warrant Subscription Agreement • May 1st, 2025 • Artelo Biosciences, Inc. • Pharmaceutical preparations • California
This Note and Warrant Subscription Agreement (this “Agreement”) is entered into by and between Artelo Biosciences, Inc., a Nevada corporation (the “Company”) and the Investors listed on Schedule A hereto and shall be effective as of the “Effective Date” as shown on the Company’s signature page hereto.
NOTE AND WARRANT SUBSCRIPTION AGREEMENTNote and Warrant Subscription Agreement • October 31st, 2025 • Artelo Biosciences, Inc. • Pharmaceutical preparations • Nevada
This Note and Warrant Subscription Agreement (this “Agreement”) is entered into as of October 28, 2025 (the “Effective Date”), by and among Artelo Biosciences, Inc., a Nevada corporation (the “Company”) and the Investors listed on Schedule A hereto (the “Investors”).